Technavio, a leading provider of market research reports, has released its latest study on Cushing Syndrome Market. This report offers a comprehensive analysis of the current market trends, emerging opportunities, and key challenges.
According to Technavio, the global Cushing Syndrome market is a segment of the expansive global pharmaceuticals market, which encompasses entities involved in the research and development (R&D) or manufacturing of various pharmaceutical offerings, including generic and non-generic drugs, as well as veterinary medicines. The size of the global healthcare industry, which includes the pharmaceuticals market, is determined by Technavio based on the consolidated revenue generated by providers of medical equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The growth of the global pharmaceuticals market is anticipated to be fueled by several key factors, including the increasing aging population, with the global population aged 60 and above projected to experience substantial growth. - The Cushing Syndrome Market is experiencing significant growth, fueled by the Growing geriatric population. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Know what is trending in the market - Access a free sample report!
The market size is estimated to grow by USD 616.66 million, at a CAGR of 14.7% during the forecast period. Rise in incidence of Cushing syndrome | Increasing growth potential in emerging economies | Use of biosimilars for Cushing syndrome treatment
For insights on company offerings- Request a sample report!
The North American Cushing Syndrome market is projected to expand at a consistent rate over the forecast period, driven by the increasing prevalence of this condition in the region. The US dominates the market due to the availability of approved treatments such as Isturisa (osilodrostat), Korlym (mifepristone), and Recorlev (levoketoconazole). Canada and Mexico are experiencing a rise in Cushing syndrome cases due to the growing incidence of hormonal disorders linked to unhealthy lifestyles. This trend positions North America as a significant contributor to the global Cushing Syndrome market.
Cushing's syndrome, a hormonal disorder caused by excessive production of cortisol, is a condition that affects approximately 15-20 people per million per year. The condition is more prevalent in the geriatric population and can be caused by various factors, including tumors in the pituitary gland or adrenal glands, chemotherapy, radiation therapy, or prolonged use of corticosteroid medication. Recent drug approvals for Cushing's syndrome include pasireotide, a somatostatin analog indicated for the treatment of Cushing's disease in adults, and mifepristone, a glucocorticoid receptor antagonist used off-label for the treatment of Cushing's syndrome. People with Cushing's syndrome may experience weight gain, round red face, acne, thinning skin, purple stretch marks, high blood pressure, abdominal obesity, weak muscles, and weak bones. Type 2 diabetes is also common in individuals with Cushing's syndrome. The condition can also lead to autoimmune diseases and inflammation. Treatment options for Cushing's syndrome include surgery to remove the tumor, radiation therapy, and medication to reduce cortisol production. Prednisone, a corticosteroid medication, can worsen symptoms in individuals with Cushing's syndrome due to its own cortisol-like effects. Therefore, it is important for individuals with Cushing's syndrome to avoid prolonged use of corticosteroid medication and seek appropriate treatment to manage their condition and prevent complications such as delicate skin, weak bones, and adipose tissue deposits.
Technavio is a global market research company offering comprehensive reports and insights on various industries. Our research helps businesses make informed decisions by providing actionable data and trends. Technavio is based on four simple principles: easy-to-access reports, robust industry coverage, a focus on new and emerging technologies, and competitive pricing. We believe in helping companies and executives become better equipped to make faster, sounder, and more effective decisions. Technavio is one of the most influential market research and advisory firms in the world. We work with business and technology leaders to provide cutting-edge market research and insights to companies.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
